ZEB2 and colorectal carcinoma: Taken together, these findings clarify the mechanism of ZEB2‐induced chemoresistance and suggest nuclear ZEB2 may have clinical utility in predicting recurrence and response to oxaliplatin‐based chemotherapy regimes in CRC.